RICCI, CHIARA
RICCI, CHIARA
Dipartimento di Scienze Farmacologiche e Biomolecolari
2-Amino-3-(phenylsulfanyl)norbornane-2-carboxylate : an Appealing Scaffold for the Design of Rac1-Tiam1 Protein-Protein Interaction Inhibitors
2014 A. Ruffoni, N. Ferri, S.K. Bernini, C. Ricci, A. Corsini, I. Maffucci, F. Clerici, A. Contini
Adalimumab in active ulcerative colitis: A "real-life" observational study
2013 A. Armuzzi, L. Biancone, M. Daperno, A. Coli, D. Pugliese, V. Annese, A. Aratari, S. Ardizzone, P. Balestrieri, F. Bossa, M. Cappello, F. Castiglione, M. Cicala, S. Danese, R. D'Incà, P. Dulbecco, G. Feliciangeli, W. Fries, S. Genise, P. Gionchetti, S. Gozzi, A. Kohn, R. Lorenzetti, M. Milla, S. Onali, A. Orlando, L. Giovanni Papparella, S. Renna, C. Ricci, F. Rizzello, R. Sostegni, L. Guidi, C. Papi
Aliskiren inhibits prorenin-induced human aortic smooth muscle cell migration
2015 N. Ferri, F. Panariti, C. Ricci, G. Maiocchi, A. Corsini
Farnesyltransferase inhibitors : CAAX mimetics based on different biaryl scaffolds
2014 V. Straniero, M. Pallavicini, G. Chiodini, P. Ruggeri, L. Fumagalli, C. Bolchi, A. Corsini, N. Ferri, C. Ricci, E. Valoti
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease
2017 F. Zimetti, P. Caffarra, N. Ronda, E. Favari, M.P. Adorni, I. Zanotti, F. Bernini, F. Barocco, M. Spallazzi, D. Galimberti, C. Ricci, M. Ruscica, A. Corsini, N. Ferri
Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages
2017 M.P. Adorni, E. Cipollari, E. Favari, I. Zanotti, F. Zimetti, A. Corsini, C. Ricci, F. Bernini, N. Ferri
Liver fat accumulation is associated with circulating PCSK9
2016 M. Ruscica, N. Ferri, C. Macchi, M. Meroni, C. Lanti, C. Ricci, M. Maggioni, A.L. Fracanzani, S. Badiali, S. Fargion, P. Magni, L. Valenti, P. Dongiovanni
Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain
2017 E. Gabriele, C. Ricci, F. Meneghetti, N. Ferri, A. Asai, A. Sparatore
New rosmaricine derivates as anticancer agents
2016 E. Gabriele, D. Brambilla, C. Ricci, N. Ferri, A. Asai, A. Sparatore
New sulfurated derivatives of cinnamic acids and rosmaricine as inhibitors of STAT3 and NF-κB transcription factors
2017 E. Gabriele, D. Brambilla, C. Ricci, L. Regazzoni, K. Taguchi, N. Ferri, A. Asai, A. Sparatore
PCSK9 AND INFLAMMATION: IN VITRO STUDY ON HEPATOCYTES AND MACROPHAGES
2018 C. Ricci
PCSK9 induces a pro-inflammatory response in macrophages
2018 C. Ricci, M. Ruscica, M. Camera, L. Rossetti, C. Macchi, A. Colciago, Z. Ilaria, L. Maria Giovanna, A. Maria Pia, C. Arrigo F G, F. Federica, A. Corsini, N. Ferri
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study
2022 G. Marasco, C. Cremon, M.R. Barbaro, D. Salvi, G. Cacciari, A. Kagramanova, D. Bordin, V. Drug, E. Miftode, P. Fusaroli, S.Y. Mohamed, C. Ricci, M. Bellini, M.M. Rahman, L. Melcarne, J. Santos, B. Lobo, S. Bor, S. Yapali, D. Akyol, F.P. Sapmaz, Y.Y. Urun, T. Eskazan, A. Celebi, H. Kacmaz, B. Ebik, H.C. Binicier, M.S. Bugdayci, M.B. Yağcı, H. Pullukcu, B.Y. Kaya, A. Tureyen, İ. Hatemi, E.S. Koc, G. Sirin, A.R. Calıskan, G. Bengi, E.E. Alıs, S. Lukic, M. Trajkovska, K. Hod, D. Dumitrascu, A. Pietrangelo, E. Corradini, M. Simren, J. Sjolund, N. Tornkvist, U.C. Ghoshal, O. Kolokolnikova, A. Colecchia, J. Serra, G. Maconi, R. De Giorgio, S. Danese, P. Portincasa, M. Di Stefano, M. Maggio, E. Philippou, Y.Y. Lee, A. Venturi, C. Borghi, M. Zoli, P. Gionchetti, P. Viale, V. Stanghellini, G. Barbara
Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain
2015 N. Ferri, G. Facchetti, S. Pellegrino, C. Ricci, G. Curigliano, E. Pini, I. Rimoldi
SOCS-3 induces PCSK9 expression in hepatic HepG2 cell line
2015 M. Ruscica, C. Ricci, C. Macchi, P. Magni, A. Corsini, N. Ferri
SOCS-3 induces proprotein convertase subtilisin kexin type 9 (PCSK9) expression in hepatic HepG2 cell line: a potential link between hypertriglyceridemia and insulin resistance
2016 M. Ruscica, C. Ricci, C. Macchi, J. Liu, P. Magni, A. Corsini, N. Ferri
STAT3 inhibition induces PCSK9 in hepatic cell line: possible involvement in hypertriglyceridemia associated with insulin resistance
2014 M. Ruscica, C. Ricci, C. Macchi, P. Magni, A. Corsini, N. Ferri
STAT3 inhibition induces PCSK9 in hepatic cell line: possible involvement in hypertriglyceridemia associated with insulin resistance
2015 C. Ricci, M. Ruscica, C. Macchi, P. Magni, A. Corsini, N. Ferri
Suppressor of cytokine signaling-3 (SOCS-3) induces proprotein convertase subtilisin kexin type 9 (PCSK9) expression in hepatic hepg2 cell line
2015 C. Ricci, M. Ruscica, C. Macchi, P. Magni, R. Cristofani, J. Liu, A. Corsini, N. Ferri
Suppressor of Cytokine Signaling-3 (SOCS-3) induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) expression in hepatic HepG2 cell line
2016 M. Ruscica, C. Ricci, C. Macchi, P. Magni, R. Cristofani, J. Liu, A. Corsini, N. Ferri